Search
Aurinia Pharmaceuticals Inc
AUPHAdd to Watchlist
16.400USD
-0.270-1.62%
Close 09-23 16:00（ET）
2.11BMarket Cap
7.36P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.62%
5 Days
-3.30%
1 Month
-1.50%
6 Months
+12.64%
Year to Date
+2.82%
1 Year
+26.15%
Key Figures
16.580Open
16.890High
74.63KVolume
7.36P/E TTM
13.35P/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
16.670Prev. Close
16.270Low
1.24MTurnover
366.77P/E Static
3.43P/B
0.00%Div Yield TTM
48.54%ROA
19.25052wk High
30.49Volume Ratio
5.75MNet Profit
128.60MShares
2.2289EPS TTM
1.43Beta
64.98%ROE
10.34052wk Low
3.66%Amplitude
92.12%Gross Margin
2.11BMarket Cap
0.59Reward/Risk
2.60%Risk Rate
More news coming soon, stay tuned...
Aurinia Pharmaceuticals Inc's Score
-0.03vs previous score
Forecast7.43
Financial Health9.26
Technical2.55
Valuation Dimensions8.43
Institutional Confidence5.00
Risk Assessment7.65
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Aurinia Pharmaceuticals Inc Technical Analysis
Technical Indicators
Sell
Summary
Neutral
Moving Average
Buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.29/0.24
Revenue / Forecast
83.22M/79.36M
Aurinia Pharmaceuticals Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolAUPH
Number of employees130
CountryCanada
Ownership
| Shareholders | Proportion |
|---|---|
| Tang Capital Management, LLC | 9.51% |
| BlackRock Institutional Trust Company, N.A. | 5.12% |
| ILJIN SNT Co., Ltd. | 5.08% |
| New Enterprise Associates (NEA) | 3.09% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 18.10% |
| Investment Advisor/Hedge Fund | 16.56% |
| Investment Advisor | 15.90% |
| Corporation | 5.08% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%Popular Instruments
51318.700
-171.300 (-0.33%)
30137.100
-340.800 (-1.12%)
7660.400
-46.600 (-0.60%)
14252.000
-170.000 (-1.18%)
65433.000
-696.000 (-1.05%)
6268.700
-21.300 (-0.34%)
93.533
+1.043 (+1.13%)
337.020
-2.730 (-0.80%)
225.510
-3.360 (-1.47%)
4262.550
-23.690 (-0.55%)
FAQs
What is the current price of Aurinia Pharmaceuticals Inc (AUPH)?
The current price of Aurinia Pharmaceuticals Inc (AUPH) is 16.40.
What is the symbol of Aurinia Pharmaceuticals Inc?
The ticker symbol of Aurinia Pharmaceuticals Inc is AUPH.
What is the 52-week high of Aurinia Pharmaceuticals Inc?
The 52-week high of Aurinia Pharmaceuticals Inc is 19.25.
What is the 52-week low of Aurinia Pharmaceuticals Inc?
The 52-week low of Aurinia Pharmaceuticals Inc is 10.34.
What is the market capitalization of Aurinia Pharmaceuticals Inc?
The market capitalization of Aurinia Pharmaceuticals Inc is 2.11B.
Is Aurinia Pharmaceuticals Inc (AUPH) currently rated as Buy, Hold, or Sell?
According to analysts, Aurinia Pharmaceuticals Inc (AUPH) has an overall rating of Buy, with a price target of 17.86.
What is the Earnings Per Share (EPS TTM) of Aurinia Pharmaceuticals Inc (AUPH)?
The Earnings Per Share (EPS TTM) of Aurinia Pharmaceuticals Inc (AUPH) is 2.23.